Got Peripheral Artery Disease?
Patients with atherosclerotic peripheral arterial disease (PAD) saw improved results from revascularization to treat intermittent claudication (IC), a common symptom of PAD, a new study found.
Anemia, Stroke and Death Risk
Anemia, a condition marked by a low red blood cell count, may increase risk of death in those who have had a stroke, according to a new study.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has approved a new treatment for Hodgkin lymphoma.
Targeted Leukemia Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved the first treatment to specifically target the B-cell lymphoma 2 (BCL-2) protein found in patients with chronic lymphocytic leukemia (CLL).
Hemophilia A Treatment Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for hemophilia A.
A New Formulation for Melphalan
The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.
Another Hemophilia Treatment Option
Patients with hemophilia B, a rare, inherited bleeding disorder, may soon have another treatment option.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.
Cancer Forecast: Leukemia on the Decline in 2016
According to new predictions, 2016 will be a good year for leukemia.
New Leukemia Rx Gets FDA Nod
Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).